Shopping Cart 0
Cart Subtotal
USD 0

Actinogen Medical Ltd (ACW) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Actinogen Medical Ltd (Actinogen), formerly Actinogen Ltd is a biotechnology company that develops novel treatments for alzheimer's disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases. The company's xanamem is a novel drug under development for the treatment of Alzheimer's disease which is designed to block the production of cortisol in the brain. It also develops drugs for the treatment of diabetes-cognitive dysfunction, cognitive dysfunction in parkinson's disease, post traumatic stress disorder, cognitive dysfunction in schizophrenia and depression, and cardiovascular disease-post myocardial infarction. Actinogen partners with other research companies to conduct clinical trials. The company operates in Australia. Actinogen is headquartered in Sydney, New South Wales, Australia.

Actinogen Medical Ltd (ACW)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Actinogen Medical Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deal Details 11

Private Equity 11

Actinogen Medical to Raise USD11.4 Million in Private Placement of Shares 11

Partnerships 13

MindMate and Actinogen Medical Enter into Agreement 13

Actinogen Enters into Research Agreement with Curtin University 14

Equity Offering 15

Actinogen Medical Raises USD0.4 Million in Share Purchase Plan 15

Actinogen Medical Raises USD0.7 Million in Share Purchase Plan 17

Actinogen Medical to Raise USD4 Million in Private Placement of Shares 18

Actinogen Prices Rights Offering of Shares for USD1 Million 19

Actinogen Raises USD8 Million in Private Placement of Shares 20

Actinogen Completes Private Placement Of Shares For USD 1.4 Million 21

Actinogen Completes Private Placement Of Shares For USD 0.06 Million 22

Actinogen Withdraws Rights Offering Of Shares For USD 0.5 Million 23

Acquisition 24

Actinogen Acquires Corticrine 24

Actinogen Medical Ltd-Key Competitors 25

Actinogen Medical Ltd-Key Employees 26

Actinogen Medical Ltd-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 28

Financial Announcements 28

Jan 31, 2018: Actinogen Medical: December 2017 Quarterly Report 28

Oct 30, 2017: Actinogen Medical: September Quarterly Update 30

Corporate Communications 32

Aug 14, 2017: Actinogen Medical announces Resignation of Director 32

Product News 33

12/01/2017: Amgen Pioneer Dr George Morstyn Joins Actinogen Board 33

10/30/2017: Actinogen Medical: September Quarterly Update 34

10/16/2017: Actinogen to be Showcased at Key Conferences 36

07/19/2017: Actinogen Medical presenting at Bioshares Biotech 2017 Summit 37

04/26/2017: Actinogen provides March quarterly update 38

02/27/2017: Actinogen announce Medical Half-Year Results 40

02/06/2018: Actinogen Medical: New data supports link between stress hormone cortisol and worsening cognition 42

Clinical Trials 43

May 31, 2018: Actinogen Medical to present at BIO International 2018 43

May 23, 2018: Actinogen Medical: Interim Analysis Recommends Continuation of XanADu Without Change 44

Apr 26, 2018: Actinogen Medical: March 2018 Quarterly Report 45

Mar 21, 2018: Mid-Way Point Reached in Landmark Alzheimer's Trial-XanADu 47

Feb 12, 2018: Actinogen Medical: Strong Recruitment Progress in Alzheimer's Trial 48

Nov 29, 2017: Early Efficacy and Safety Data Read-Out Planned for Alzheimer's Trial 49

Nov 22, 2017: Leading Alzheimer's Researchers to Address Shareholders 50

Sep 07, 2017: Actinogen Medical: First patient completes landmark Alzheimer's disease trial 51

Aug 16, 2017: First UK patient treated in ground-breaking Alzheimer's clinical trial 52

Jul 26, 2017: Actinogen Medical Provides Update on Xanamem 53

Jun 22, 2017: First US patients treated in landmark Alzheimers disease trial 55

Jun 01, 2017: First UK site goes live in global Alzheimer's disease clinical trial 56

May 16, 2017: First patient treated in landmark Alzheimer's disease clinical trial 57

Mar 08, 2017: TGA Regulatory Approval Received for Alzheimer's Phase II Trial 59

Feb 09, 2017: Xanamem research published in prestigious medical journal 60

Jan 10, 2017: UK Regulatory Approval for Alzheimer's Disease Clinical Trial-XanADu 61

Jan 03, 2017: FDA Approval to Commence Alzheimers Disease Clinical Trial 62

Other Significant Developments 63

Jul 25, 2018: Actinogen Medical: June 2018 quarterly report 63

Appendix 65

Methodology 65

About GlobalData 65

Contact Us 65

Disclaimer 65


List Of Figure

List of Figures

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9


List Of Table

List of Tables

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Actinogen Medical Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Actinogen Medical Ltd, Deals By Therapy Area, 2012 to YTD 2018 9

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Actinogen Medical to Raise USD11.4 Million in Private Placement of Shares 11

MindMate and Actinogen Medical Enter into Agreement 13

Actinogen Enters into Research Agreement with Curtin University 14

Actinogen Medical Raises USD0.4 Million in Share Purchase Plan 15

Actinogen Medical Raises USD0.7 Million in Share Purchase Plan 17

Actinogen Medical to Raise USD4 Million in Private Placement of Shares 18

Actinogen Prices Rights Offering of Shares for USD1 Million 19

Actinogen Raises USD8 Million in Private Placement of Shares 20

Actinogen Completes Private Placement Of Shares For USD 1.4 Million 21

Actinogen Completes Private Placement Of Shares For USD 0.06 Million 22

Actinogen Withdraws Rights Offering Of Shares For USD 0.5 Million 23

Actinogen Acquires Corticrine 24

Actinogen Medical Ltd, Key Competitors 25

Actinogen Medical Ltd, Key Employees 26

Actinogen Medical Ltd, Subsidiaries 27

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Actinogen Medical Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Actinogen Medical Ltd (Actinogen), formerly Actinogen Ltd is a biotechnology company that develops novel treatments for alzheimer's disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases. The company's xanamem is a novel drug under development for the treatment of Alzheimer's disease which is designed to block the production of cortisol in the brain. It also develops drugs for the treatment of diabetes-cognitive dysfunction, cognitive dysfunction in parkinson's disease, post traumatic stress disorder, cognitive dysfunction in schizophrenia and depression, and cardiovascular disease-post myocardial infarction. Actinogen partners with other research companies to conduct clinical trials. The company operates in Australia. Actinogen is headquartered in Sydney, New South Wales, Australia.

Actinogen Medical Ltd (ACW)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Actinogen Medical Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deal Details 11

Private Equity 11

Actinogen Medical to Raise USD11.4 Million in Private Placement of Shares 11

Partnerships 13

MindMate and Actinogen Medical Enter into Agreement 13

Actinogen Enters into Research Agreement with Curtin University 14

Equity Offering 15

Actinogen Medical Raises USD0.4 Million in Share Purchase Plan 15

Actinogen Medical Raises USD0.7 Million in Share Purchase Plan 17

Actinogen Medical to Raise USD4 Million in Private Placement of Shares 18

Actinogen Prices Rights Offering of Shares for USD1 Million 19

Actinogen Raises USD8 Million in Private Placement of Shares 20

Actinogen Completes Private Placement Of Shares For USD 1.4 Million 21

Actinogen Completes Private Placement Of Shares For USD 0.06 Million 22

Actinogen Withdraws Rights Offering Of Shares For USD 0.5 Million 23

Acquisition 24

Actinogen Acquires Corticrine 24

Actinogen Medical Ltd-Key Competitors 25

Actinogen Medical Ltd-Key Employees 26

Actinogen Medical Ltd-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 28

Financial Announcements 28

Jan 31, 2018: Actinogen Medical: December 2017 Quarterly Report 28

Oct 30, 2017: Actinogen Medical: September Quarterly Update 30

Corporate Communications 32

Aug 14, 2017: Actinogen Medical announces Resignation of Director 32

Product News 33

12/01/2017: Amgen Pioneer Dr George Morstyn Joins Actinogen Board 33

10/30/2017: Actinogen Medical: September Quarterly Update 34

10/16/2017: Actinogen to be Showcased at Key Conferences 36

07/19/2017: Actinogen Medical presenting at Bioshares Biotech 2017 Summit 37

04/26/2017: Actinogen provides March quarterly update 38

02/27/2017: Actinogen announce Medical Half-Year Results 40

02/06/2018: Actinogen Medical: New data supports link between stress hormone cortisol and worsening cognition 42

Clinical Trials 43

May 31, 2018: Actinogen Medical to present at BIO International 2018 43

May 23, 2018: Actinogen Medical: Interim Analysis Recommends Continuation of XanADu Without Change 44

Apr 26, 2018: Actinogen Medical: March 2018 Quarterly Report 45

Mar 21, 2018: Mid-Way Point Reached in Landmark Alzheimer's Trial-XanADu 47

Feb 12, 2018: Actinogen Medical: Strong Recruitment Progress in Alzheimer's Trial 48

Nov 29, 2017: Early Efficacy and Safety Data Read-Out Planned for Alzheimer's Trial 49

Nov 22, 2017: Leading Alzheimer's Researchers to Address Shareholders 50

Sep 07, 2017: Actinogen Medical: First patient completes landmark Alzheimer's disease trial 51

Aug 16, 2017: First UK patient treated in ground-breaking Alzheimer's clinical trial 52

Jul 26, 2017: Actinogen Medical Provides Update on Xanamem 53

Jun 22, 2017: First US patients treated in landmark Alzheimers disease trial 55

Jun 01, 2017: First UK site goes live in global Alzheimer's disease clinical trial 56

May 16, 2017: First patient treated in landmark Alzheimer's disease clinical trial 57

Mar 08, 2017: TGA Regulatory Approval Received for Alzheimer's Phase II Trial 59

Feb 09, 2017: Xanamem research published in prestigious medical journal 60

Jan 10, 2017: UK Regulatory Approval for Alzheimer's Disease Clinical Trial-XanADu 61

Jan 03, 2017: FDA Approval to Commence Alzheimers Disease Clinical Trial 62

Other Significant Developments 63

Jul 25, 2018: Actinogen Medical: June 2018 quarterly report 63

Appendix 65

Methodology 65

About GlobalData 65

Contact Us 65

Disclaimer 65


List Of Figure

List of Figures

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9


List Of Table

List of Tables

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Actinogen Medical Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Actinogen Medical Ltd, Deals By Therapy Area, 2012 to YTD 2018 9

Actinogen Medical Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Actinogen Medical to Raise USD11.4 Million in Private Placement of Shares 11

MindMate and Actinogen Medical Enter into Agreement 13

Actinogen Enters into Research Agreement with Curtin University 14

Actinogen Medical Raises USD0.4 Million in Share Purchase Plan 15

Actinogen Medical Raises USD0.7 Million in Share Purchase Plan 17

Actinogen Medical to Raise USD4 Million in Private Placement of Shares 18

Actinogen Prices Rights Offering of Shares for USD1 Million 19

Actinogen Raises USD8 Million in Private Placement of Shares 20

Actinogen Completes Private Placement Of Shares For USD 1.4 Million 21

Actinogen Completes Private Placement Of Shares For USD 0.06 Million 22

Actinogen Withdraws Rights Offering Of Shares For USD 0.5 Million 23

Actinogen Acquires Corticrine 24

Actinogen Medical Ltd, Key Competitors 25

Actinogen Medical Ltd, Key Employees 26

Actinogen Medical Ltd, Subsidiaries 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Actinogen Medical Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.